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ABSTRACT: 
Importance of extracellular vesicles as multifunctional tools of intercellular communication has 
grown during last fifteen years. All cell types secrete these vesicles which conceal, among other 
things, RNA, DNA and proteins inside a bilipid layer. With the help of these vesicles, cells can send 
molecules to other cells, even in a distance. The bilipid layer prevents degradation of the contents of 
the vesicles. The role of extracellular vesicles in the development of cancer has been studied 
intensively and promising findings have been obtained. Metastasis and invasion of cancer cells 
require communication between cancer cells and their environment. Especially the use of 
extracellular vesicles as biomarkers for cancer seem to be possible.  
In this study microscopic and functional studies were performed with extracellular vesicles isolated 
from cultured cells and from human body fluids. Human fibroblasts were used as target cells to 
study the effect of stable inducible EGFP-HAS3-MV3 melanoma cell -derived vesicles on their 
migration and invasion speed. Both of these properties are important in cancer metastasis. Secretion 
of extracellular vesicles were imaged with live cell confocal microscopy. Transmission electron 
microscopy (TEM) was used to image extracellular vesicles from different sources.  Because of 
their small size, 30-500 nm, examination of extracellular vesicles requires high resolution from 
research equipment.  
The results obtained in this study show that transmission electron microscopy and confocal 
microscopy are useful methods to study the ultrastructure, diameter and secretion mechanisms of 
extracellular vesicles as well as their effects on target cell behavior. Effects of extracellular vesicles 
isolated from melanoma-derived vesicles to the human fibroblast migration are quite low. However, 
there is an increase in invasion efficiency in those cells which were given melanoma-derived 
vesicles. After all further studies are needed.  
ABBREVIATIONS 
ADP Adenosine diphosphate 
DMEM Dulbecco’s modified eagle medium 
ERK Extracellular signal-regulated kinase 
EMT Epithelial mesenchymal transition 
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GTP guanosine-5'-triphosphate 
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MHC  Major histocompatibility complex 
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MVB Multivesicular body 
RAB Ras related protein in brain 
SNARE Soluble NSF attachment protein receptor 
TAT-5 Transbilayer amphipathic transporter 5 
TEM Transmission electron microscopy 
TGN Trans-golgi –network 
TSG-101  Tumor sysceptibility gene 101 
VAMP Vesicle associated membrane protein 
VSP-27 Vacuolar protein sorting protein 27  
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1 INTRODUCTION 
1.1. EXTRACELLULAR VESICLES 
1.1.1. Extracellular vesicles – Anything but dust 
Extracellular vesicles are secreted by the most of cell types and exist all over in our body. They are 
small vesicles which are surrounded by phospholipid bilayer. There are three main types of 
extracellular vesicles: exosomes (Trams, et al. 1981, Johnstone, et al. 1987), microvesicles (Holme, 
et al. 1994) and apoptotic bodies (Kerr, et al. 1972). In this thesis the focus is on exosomes and 
microvesicles. Exosomes are secreted from cells through the lysosomal machinery. In turn 
microvesicles are formed by direct budding from the cell surface.  
In literature cell-derived vesicles have been suggested to have multiple functions. These functions 
are for example regulation of angiogenesis (Skog, et al. 2008a), cell signaling, inflammation and 
immune response (Bhatnagar, et al. 2007), maintaining homeostasis, cell waste management (Sims, 
et al. 1988, de Gassart, et al. 2003a) and blood coagulation (Chargaff and West. 1946). 
Extracellular vesicles were found for the first time with transmission electron microscopy in Peter 
Wolf’s blood coagulation study in 1967. They found out that small vesicles were detached from 
cells and called these vesicles as “platelet dust”. These vesicles were thought to be just cell waste. 
(Wolf. 1967) 
Cell-derived vesicles have been found almost all-over in our body after their discovery. Vesicles 
have been found from semen (Ronquist and Brody. 1985), ascites fluid (Andre, et al. 2002), 
bronchoalveolar lavage (Admyre, et al. 2003), urine (Pisitkun, et al. 2004), blood (Caby, et al. 
2005), synovial fluid (Skriner, et al. 2006), breast milk (Admyre, et al. 2007), amniotic fluid 
(Keller, et al. 2007), saliva (Ogawa, et al. 2008), cerebrospinal fluid (Harrington, et al. 2009), nasal 
secretions (Lasser, et al. 2011) and bile (Masyuk, et al. 2010). 
 
1.1.2. Nomenclature and classification of extracellular vesicles 
Size of extracellular vesicles varies from 30 nm to 2000 nm. Vesicles can be classified in three 
classes based on their biogenesis i.e. exosomes (Trams, et al. 1981, Johnstone, et al. 1987), 
microvesicles (Holme, et al. 1994) and apoptotic bodies (Kerr, et al. 1972). Exosomes are smallest 
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type of vesicles and their size varies between 30 and 120 nm. In turn, size of microvesicles is 
between 50 and 1000 nm. Apoptotic bodies are largest and their diameter is 500-2000 nm (El 
Andaloussi, et al. 2013). 
In addition to biogenesis, vesicles can also be classified by their origin and biological function. 
Thus, EVs are named as argosomes (Greco, et al. 2001), tolerosomes (Karlsson, et al. 2001), 
prostasomes (Brody, et al. 1983), ectosomes (Stein and Luzio. 1991), deteriosomes (Yao, et al. 
1993), microparticles (Mackman. 2009), sebosomes (Nagai, et al. 2005), cardiosomes 
(Waldenstrom, et al. 2012) and oncosomes (Morello, et al. 2013). Abundance of possible names for 
extracellular vesicles is a reason why a debate for standardizing the nomenclature is currently 
ongoing. Approved nomenclature will make both cooperation and reading of other groups’ papers 
easier. 
 
1.1.3. Biogenesis of exosomes 
Exosomes originate via endosomal pathway (Figure 1). When an early endosome matures to a late 
endosome by acidification, intraluminal vesicles (ILVs) form by reverse budding from cytoplasm 
into the lumen of the endosome. While ILVs bud to late endosome, mRNA, microRNA, DNA, 
proteins and lipids are packed inside these vesicles. After budding of intraluminal vesicles the late 
endosome is called as a multivesicular body (MVB) (Johnstone, et al. 1987). Multivesicular body 
may fuse with a lysosome when it and its cargo will be degradated. Another scenario is that the 
multivesicular body fuses with the plasma membrane (Futter, et al. 1996). In this case the 
intraluminal vesicles are released to the extracellular space and after that they are called exosomes 
(Trams, et al. 1981, Harding, et al. 1983). It is also possible that MVBs act as a storage for some 
important molecules as in the case of MHC class II in dendritic cells (Kleijmeer, et al. 2001). 
What is then a molecular machinery behind sorting of cargo to intraluminal vesicles/exosomes? 
There is not currently a certain answer to that question, but several possible pathways are described 
in multiple publications. Sorting of cargo in MVB takes place in two steps. In the first step of the 
process, specific proteins at the outer membrane of the late endosome are gathered together. In the 
second step an intraluminal vesicle buds inside the endosome. Best quess is probably a pathway that 
is regulated by ESCRT machinery (endosomal sorting complexes required for transport) 
(Katzmann, et al. 2001) . This is a  reason why common classification of MVB-formation routes is 
to divide them to ESCRT-dependent and ESCRT-independent routes.  
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One observation is that monoubiquitinylation leads to packing of molecules to the multivesicular 
bodies.  However all the cargo of multivesicular bodies are not ubiquitinylated which tells that 
ubiquitinylation is not necessary and there might be other mechanisms. (Buschow, et al. 2005) Also 
it has to be remembered that polyubiquitinylation is a signal that leads to degradation of its targets. 
With the help of VSP-27, ESCRT -0, -I and –II can identify ubiquitinylated molecules. VSP-27 also 
provides TSG-101 to help. TSG-101, in turn, recruits AIP/Alix (ALG-2-interacting protein 4), 
which is responsible for membrane budding. Also VTA1 (vacuolar protein sorting-associated 
protein 1) is thought to be needed on ESCRT –dependent route. ESCRT complexes are also needed 
for leading membranes for lysosomes to degradation. (von Schwedler, et al. 2003) Ability of 
ESCRT-II to bind mRNA advocates the possibility of participitation of ESCRT machinery in 
sorting of exosome cargo (Irion and St Johnston. 2007).  
In the light of current knowledge it is assumed that also ESCRT independent pathway exists. In this 
pathway a lipid called ceramide is in the biggest role. Ceramide may initiate the secretion of 
exosomes. Biosynthesis of ceramide is regulated by neutral sphingomyelinase 2 (nSMase2). 
(Trajkovic, et al. 2008, Kosaka, et al. 2010) 
Also in some studies clustering of exosomal cargo seems to play important role in exosome loading.  
It is called as a luminal domain dependent pathway, a passive mechanism, which is independent 
from ESCRT, ubiquitination and Hrs.  Enrichment of tetraspanins and cholesterol are linked to 
protein sorting to intraluminal vesicles. (de Gassart, et al. 2003b, Theos, et al. 2006) 
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Figure 1. Exosomes originate via endosomal pathway. While an early endosome matures to the late 
endosome, intraluminal vesicles (ILV) bud into the endosome. After budding of intraluminal 
vesicles, the endosome is called as a multivesicular body (MVB). MVB may end up to lysosomal 
degradation or fuse with the plasma membrane. In the later phase intraluminal vesicles are released 
to extracellular space and called as exosomes. 
 
1.1.4. Secretion of exosomes 
As in the biogenesis of exosomes also molecular mechanisms behind secretion of exosomes remain 
still unclear but it is ravelling is in the process. It is known that secretion of exosomes is controlled 
by many factors. Multiple members of RAB (Ras-related protein in brain) – protein family have 
been found out to be part of the machinery of the exosome secretion. The RAB family members are 
small GTPase proteins. The role of these small GTPase proteins in exosome secretion is the 
movement of multivesicular body to the plasma membrane. (Stenmark. 2009) 
When the multivesicular body and the plasma membrane are in touch, soluble NSF attachment 
protein receptor complexes (SNAREs) take over the fusion of MVB with plasma membrane 
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(Zylbersztejn and Galli. 2011). For fusion at least SNAP-23 (Castle, et al. 2002), VAMP-7 
(Hirashima. 2000) and VAMP 8 are needed (Luzio, et al. 2005). Fusion process is also Ca
2+
 
regulated in the case of secretory lysosomes. All the MVB secretion is not, however, regulated by 
SNAREs. 
 
1.1.5. Biogenesis of microvesicles 
Another type of extracellular vesicles are microvesicles. Microvesicles form via direct budding 
from cell membrane (Figure 2). Microvesicles are also called as ectosomes (Stein and Luzio. 1991) 
and microparticles (Mackman. 2009) in literature. Recognition between exosomes and 
microvesicles is difficult because size ranges of these two type of vesicles partially overlap. In 
many cases their complete separation is just impossible. 
Microvesicles are associated with the cell apoptosis. Budding of microvesicles is a multistep 
process which starts with certain stimulus like cell stress. This leads to increase of calcium 
concentration in cytosol followed by enzymatic activity of calpains, gelsolins, scramblases and 
kinases. The activation of above-mentioned enzymes causes inhibition of translocases and 
phosphatases. This finally enables formation of microvesicle via alterations in cytoskeleton. The 
fact that platelets are able to produce microvesicles after inhibition of calpain shows that also other 
pathways exist for microvesicle formation. (Wiedmer and Sims. 1991, VanWijk, et al. 2003)  
Structure of the plasma membrane is closely linked to biogenesis of microvesicles 
Aminophosphotranslocases regulate the structure of the cell membrane. Function of 
aminophospotrans-locases is to transfer phospholipids from one side to another of the cell 
membrane which consists of bilipid layer. Transfer of phosphatidylserine to the outer leaflet of cell 
membrane promotes budding of microvesicles (Hugel, et al. 2005)  
Another factor that affects the structure of the plasma membrane and consequently to the 
microvesicle formation is distribution of phosphatidylenolamine between inner and outer leaflet of 
the plasma membrane. It has been found out that the phosphatidylenolamine –translocase (TAT-5) 
regulates secretion of extracellular vesicles in the study performed using Caenorhabtidis elegans. In 
normal state phosphatidylenolamine is unevenly distributed between outer and inner leaflet of 
plasma membrane so that only few phosphatidylenolamine exists at outer leaflet. In TAT-5 mutants 
phosphatidylenolamine is transferred to the outer leaflet which enables attachment of endosomal 
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sorting complexes to the inner leaflet of the plasma membrane. This makes microvesicle formation 
possible. (Tuck. 2011) 
Contraction of cytoskeleton, which consists of actin and myosin, is the final step that is needed to 
the microvesicle budding. This is due to that ARF6-GTP (ADP ribosylation factor 6 that binds 
GTP) activates phospholipase D. After that ERK (extracellular signal-regulated kinase) attaches to 
plasma membrane. ERK phosphorylates MLCK (Myosin light chain kinase). Phosphorylation 
activates MLCK, which leads to phosphorylation of the light chain of myosin. (Muralidharan-Chari, 
et al. 2009) 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Microvesicles are 50 – 1000 nm -sized plasma membrane bubbles which are formed via 
direct budding from the cell surface.  
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1.2. ROLE OF EXTRACELLULAR VESICLES IN HEALTH AND DISEASE  
 
1.2.1. Extracellular vesicles – multitools of cells 
Both exosomes and microvesicles have been thought to be part of intercellular communication 
because they transfer biomolecules between cells. Extracellular vesicles are necessary for the 
functions of multicellular species. They play a big role in intercellular communication by sending 
messages to other cells in the shape of transmembrane receptors, mRNAs, miRNAs, proteins and 
signaling molecules which are carried to target cells wrapped in tiny cell membrane envelopes. This 
communication is a way of manipulation the extracellular environment. 
Recent study points out interestingly that exosomes and microvesicles differ in their ability to 
transfer information between cells. The study which was performed using transiently transfected 
cells showed that reported proteins and mRNA were successfully sealed in both types of vesicles 
but only microvesicles managed to convey reporter function to target cells.(Kanada, et al. 2015) It 
may still be too early to make too radical conclusion about different abilities of these two types of 
extracellular vesicles. 
Another study shows that exosomes derived from breast cancer carcinoma cell cultures are able to 
increase cell movement. This study compared the effects of three breast cancer cell lines with 
different metastatic potential and showed that increase of the cell movement correlated with the 
metastatic potential of donor cells. Exosomes have been found to have unique protein signatures 
depending from which cell they originate.(Harris, et al. 2015) 
 
1.2.2. Potential of extracellular vesicles as biomarkers 
Liquid biopsy is currently being developed alongside traditional biopsy which means taking of 
piece of tissue from patient. Liquid biopsy, in turn, is much easier to obtain from the patient because 
it can be taken from body fluids, especially, if tumor exists deep in the body. In short, the principle 
of liquid biopsy is that biomarkers are observed from the sample. Extracellular vesicles, which are 
present in every bodily fluid and secreted from every cell type are very potential biomarkers in 
liquid biopsies. This kind of liquid biopsy could be taken from blood or urine so the invasiveness of 
sampling is very low if it exists at all. Real-time monitoring is also possible by liquid biopsies.  
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Utilization of extracellular vesicles as biomarkers for screening of several diseases have been 
studied for years. Exosomes and microvesicles have same features as their parent cells such as same 
surface receptors. RNA and protein content of EVs is also dependent on the original cell type. 
Possibilities of using extracellular vesicles as diagnostic tools are great. Screening of abundance and 
content of extracellular vesicles may bring out useful information about diseases which are not yet 
observed. They can also be used as tools for monitoring progression of diseases which have been 
already diagnosed. 
 
1.2.3. Using of extracellular vesicles as biomarkers for cancer 
There is more and more information about importance of interaction between cancer cells and their 
environment to development of tumors. Cancer cells manipulate surrounding cell types to enable 
penetration and growth. Extracellular vesicles have been found to play a key role in this interaction. 
Especially exosomes act as messengers which carry biomolecules between cells. Tumor-derived 
exosomes has been found out to interact with tumor environment for example by promoting 
angiogenesis, stimulating the cell movement and evading immune system. (Clayton, et al. 2007, 
Skog, et al. 2008b, Harris, et al. 2015) 
It can be easily thought that these extracellular vesicles transport messages only to cells nearby. 
Extracellular vesicles carry out also long-distance communication. (Kadiu, et al. 2012) These tiny 
shuttles have often been observed to contain tumor antigens indicating that they are originated from 
the tumor. Nowadays, it is generally known that extracellular vesicles can transfer mRNA and 
proteins in functional form between cells, which advocates their importance to tumor development. 
Protein p53 is an important regulator of cell cycle, closely associated to cancer development and has 
been found out to regulate amount of TSAP6 which increases secretion of exosomes.  (Yu, et al. 
2006) 
In light of the considerations set out above it is not surprising that the use of extracellular vesicles as 
biomarkers for cancer is studied extensively. Various approaches to utilize extracellular vesicles, 
especially exosomes, as biomarkers have been carried out and promising results have been 
obtained. Until now possibly applicable biomarkers have been detected related to several common 
cancers as lung cancer, prostate cancer, breast cancer and ovarian cancer. (Rabinowits, et al. 2009, 
Li, et al. 2009, Mitchell, et al. 2009, Le, et al. 2014) 
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In 2008, Taylor et al. measured amount of eight different microRNAs and pointed out that 
exosomal microRNA can be used to recognize ovarian cancer. (Taylor and Gercel-Taylor. 2008) 
Next year Li et al. found out that those exosomes in peripheral circulation which contain claudin 
have a connection to ovarian cancer (Li, et al. 2009).  
A few markers have been found from extracellular vesicles linked to prostate cancer. In 2009 
Prostate-Specific Antigen (PSA) and Prostate-Specific Membrane Antigen (PSMA) were noticed to 
act as biomarkers for prostate cancer. (Mitchell, et al. 2009). Also increased levels of a protein 
called survivin in plasma exosomes were linked to prostate cancer (Khan, et al. 2012) 
Additionally, a recent study (Melo, et al. 2015) suggests that glypican-1, a proteoglycan anchored to 
the membranes of circulating extracellular vesicles, could be utilized as a specific marker for 
pancreatic cancer. 
Levels of exosomal RNA in blood may act as an indicator in screening of lung cancer. Remarkable 
differences between lung cancer patients and control group have been measured. Also similarity 
between tumor miRNA and exosomal RNA in blood samples in lung cancer patients were observed. 
(Rabinowits, et al. 2009) 
Levels of microRNA 200 family members are increased in metastatic breast cancer cells. Metastatic 
potential also may be transferred from metastatic cells to non-metastatic cells via microRNA-200 –
containing extracellular vesicles. (Le, et al. 2014) 
 
1.3. HYALURONAN 
First time hyaluronic acid was found in 1934 when Karl Meyer observed vitreous of bovine eye 
(Meyer, et al. 1934). This high molecular weight polysaccharide has since been found to exist all 
over our body in connective tissues. A high capacity to retain water is one of it’s specific features. 
(Kogan, et al. 2007) In 1986 hyaluronic acid was given a name hyaluronan. This new name 
followed standardization of polysaccharide nomenclature. (Balazs, et al. 1986) 
 
1.3.1. Structure and synthesis 
In a nutshell, hyaluronan is a mucopolysaccharide which is synthesized by hyaluronan synthases 
and degraded by hyaluronidases. Hyaluronan is a linear glycosaminoglycan which consists of 
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disaccharides D-glucuronic acid (GlcUA) and N-acetyl-D-glucosamine (GlcNAc) linked together 
by alternating β-1,4 and β-1,3 glycosidic bonds. Unlike other glycosaminoglycans, HA does not go 
through other chemical modification like sulfation or acetylation. (Weissmann and Meyer. ) 
Synthesis of hyaluronan takes place at plasma membrane. HA is synthesised by three hyaluronan 
synthases, HAS1-3, in mammals.(Weigel and DeAngelis. 2007)  
 
1.3.2. General role of hyaluronan 
Otherwise than originally thought hyaluronan is not only the space-filler althought it is the main 
component of extracellular matrix. Several other roles has been associated with hyaluronan 
molecule. Maintaining the homeostasis is important role of hyaluronan. It has been found out to be 
key player in wound healing (Aya and Stern. 2014). Hyaluronan has also multiple ways to regulate 
inflammation, which is important part in cancer development. It has been also linked to 
morphogenetic processes which means that HA regulates development. HA has an effect in 
angiogenesis, skeleton development, chondrogenesis and cell proliferation.(Tammi, et al. 2002) 
Hyaluronan should not be thought only unambiguous molecule. The molecular weight of 
hyaluronan seem to be important factor in regulating the effects of hyaluronan.(Cowman, et al. 
2015)  
 
1.3.3. Hyaluronan, extracellular vesicles and cancer 
According to a recent finding, hyaluronan is associated with enhanced microvesicle production in 
cell cultures. (Rilla, et al. 2013)This suggests that plasma membrane shedding of the vesicles 
carrying hyaluronan on their surface could enable the horizontal transfer of hyaluronan from tumor 
cells into the surrounding stroma and enhance tumor-stroma interactions. Additionally, the HA-
coated EVs may offer both a potential therapeutic target and a diagnostic tool in cancers and other 
disease states with excess hyaluronan secretion.(Rilla, et al. 2014) Therefore, it is important to solve 
the mechanisms that regulate their shedding, to develop novel methods for their identification and 
clarify their functional effects on target cells. One of the main objectives of this study is to find 
answers to these questions. 
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Figure 3. Human melanoma cells (MV3) with inducible expression of GFP-HAS3. The left 
panel shows a group of cells without induction and right panel cells after induction of GFP-HAS3 
expression. Note the increased number of EVs in HAS3-overexpressing cells (arrow). Green color 
shows GFP-HAS signal, red color CD44 immunostaining and blue color indicated nuclei 
(unpublished data by Kirsi Rilla).  
 
1.4. ISOLATION OF EXTRACELLULAR VESICLES 
 
1.4.1. Challenges in vesicle isolation 
Currently there is not only one proper protocol to isolate extracellular vesicles. One big reason for 
this is that EVs can be isolated from multiple different sample sources. Also amount of available 
sample material and other follow-up measurements affect the choice of the protocol. 
When purification and isolation procedures are planned for extracellular vesicles, it’s important to 
remember that there is not only one uniform type of vesicles. Each type of extracellular vesicles 
needs suitable isolation procedure. It may lead to large errors if this is not taken into account. 
Once again problems in isolating extracellular vesicles is caused by their small size. List of 
commonly used isolation methods includes ultracentrifugation with/without a sucrose gradient, 
ultrafiltration, size exclusion chromatography, affinity capture of magnetic/non-magnetic beads and 
polymer based precipitation. 
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In a recent study performed by Jae-Jun Ban et al. attention has been paid to impact of pH to yield of 
exosome isolation. Interest underlying in the background for this study were the effect of changes of 
pH in some diseases as cancer and Creutzfeldt-Jakob disease. In cancer low pH has been closely 
linked in the metastasis and progression of cancer. Exosomes have also been found to have a hand 
in Creutzfeldt-Jakob disease progression. Differences in exosomal protein and RNA yields turned 
out to be remarkably high. Levels of total exosomal protein and RNA were measured in medium 
with three different pHs which were 4, 7 and 11. Acidic medium gave the best result. The second 
best result was obtained with neutral conditions and the lowest yield, in turn, was due to alkaline 
pH. In the light of the results is not in vain to draw attention to pH in exosome studies from now. 
(Ban, et al. 2015)  
As mentioned before, the isolation method of extracellular vesicles depends on the type of vesicles 
to be isolated. A sample type is another major issue that should be noted. Each sample type has its 
own specific requirements to achieve the desired outcome. Sample types can be roughly divided 
into two major classes: Extracellular vesicles isolated form cell culture media and extracellular 
vesicles isolated from body fluids. Both of these fluid types have their own possible sources of 
error. 
When extracellular vesicles are isolated from cell cultures it should be kept in mind that 
supplements which are added to the cell cultures may function as artificial EV sources. Especially 
fetal bovine serum (FBS) contains vesicles that may cause incorrect observations.  Filtering and 
ultracentrifugation for 18 h at 100 000 x g or greater are used to remove these vesicles. Shorter 
ultracentrifugation step won’t remove all the vesicles.(Shelke, et al. 2014) In addition to used 
supplements one source of error is culture media itself. Even fresh culture media includes particles 
of the same size range as the extracellular vesicles. There is different amounts of these particles in 
media from different manufacturers. Number of these particles alters during storage and those 
media which are stored in 4 ˚C have less background than those which are stored in room 
temperature. The cell line used also influences the choice of best protocol. (Jeppesen, et al. 2014) 
When extracellular vesicles are isolated from body fluids the complexity of samples is a challenge. 
Body fluids contain lipoproteins, DNA, RNA, protein aggregates, microbes and platelets which may 
cause problems in isolation. (Szatanek, et al. 2015)  
Platelet-derived extracellular vesicles are the only group of EVs that has accurately determined 
instructions for storage and isolation. The fresher the better may be a consensus for getting the best 
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yield of extracellular vesicles. Storing temperature and number of freezing and thawing cycles are 
critical factores affecting the quality of the samples. 
 
1.4.2. Ultracentrifugation  
Ultracentrifugation is the most common method to isolate extracellular vesicles. In 
ultracentrifugation particles are separated based on their size and density so that larger and more 
dense particles travel farther from a central axis.(Beams, et al. 1933).  
Nowadays the most widely used method for extracellular vesicle isolation is differential/ 
ultracentrifugation. (Witwer, et al. 2013) The main guidelines for this method has been introduced 
in study performed by Raposo et al. but there is variations depending on different laboratories and 
studied cell lines. In the study of Raposo et al. exosomes were purified from the conditioned media 
of transformed human b cell lines. Although used centrifugation speed depends on studied 
extracellular vesicles and cell lines, mainly the following speeds are used: 300 x g to remove cells, 
2000 x g to remove dead cells and apoptotic bodies, 10 000 – 20 000 x g to isolate microvesicles 
and remove cell debris, 100 000 – 200 000 x g to isolate exosomes. (Raposo, et al. 1996) When 
microvesicles are wanted to be isolated 10 000 x g -20 000 x g is enough. Too high centrifugal 
forces will lead to vesicle degradation and fusion. (van der Pol, et al. 2012) Between each 
centrifugation step supernatant is collected to a new test tube. It is important to validate the 
centrifugation process according to which size of particles are wanted to be isolated. This will 
maximize the purity and yield. Common in used procedures is that centrifugation steps are 
performed in 4˚C except plasma samples. If plasma samples are handled in 4˚C, plateled EVs are 
formed which are interfering further processing.(Szatanek, et al. 2015)                                                                                                                                                                                                                                                       
There is a variation of differential/ultracentrifugation step which uses additional sucrose 
gradient/cushion step. Reason for using this step is to prevent possibly non-specific proteins to end 
up to EV samples. In this step the sample is loaded into tube containing Tris/sucrose/D2O and 
centrifuged at least 75 minutes at 75 000 x g followed by collection of fraction which density is 
1.13 - 1.19 g/ml. This fraction is centrifuged again at 100 000 x g after dilution with PBS. (Escola, 
et al. 1998, Thery, et al. 2006) 
There is multiple problems which should be noted when using ultracentrifugation.  Cargo of 
vesicles affects their density so that it is not possible to make strict size separation.  
Ultracentrifugation is also time consuming because it is quite slow when the number of samples is 
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high. Need for high sample volumes causes that it is not able to use with all clinical samples and 
other samples with small volume. Some vesicles may break down when they are put to 
ultracentrifuge with high velocity. Also many contaminants may be pelleted with ultracentrifuge. 
(Peterson, et al. 2015) 
 
1.4.3. Size exclusion chromatography 
In size exclusion chromatography particles will be separated depending on their size. Particles with 
different sizes have different abilities to go through stationary phase of size exclusion column i.e. 
elution speed is different. (Boing, et al. 2014) Normally low-speed centrifugation and filtration is 
done to samples before chromatography. (Muller, et al. 2014) Centrifugation removes large 
particles and filtration concentrates the sample. As the other methods also size exclusion 
chromatography has its own disadvantages. Too high force in filtering EVs may make structural 
changes to vesicles. Also selection of proper chromatography column should be carried out 
carefully. (Witwer, et al. 2013)  
 
1.4.4. Ultrafiltration (UF) 
In ultrafiltration the sample is filtered through a semipermeable membrane. This method is often 
combined with other isolation methods like ultracentrifugation and size exclusion chromatography 
(Lamparski, et al. 2002, Nordin, et al. 2015). It can be also used without combination with other 
methods, resulting in higher purity of the samples as compared to other methods. Main problems 
associated with ultrafiltration techniques are clogging and shear stress which may lead to unwanted 
changes in the properties like morphology of the extracellular vesicles. 
 
1.4.5. Immuno-affinity purification 
Immunoaffinity isolation is a technique which utilizes the information about proteins on the surface 
of extracellular vesicles. The fact that extracellular vesicles resemble their parent cells is very useful 
for this technique. By selecting the correct antibodies the desired vesicles can be distinquished from 
other material. Depending on the approach immunoaffinity isolation can be used to remove 
unwanted vesicles from the sample or to enrich wanted vesicles. Advantage of immunoaffinity 
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isolation is that in this method the isolation of extracellular vesicles is based on marker expression 
on their surface rather than their diameter.  
Used antibodies are attached for example to matrix or magnetic/non-magnetic microbeads. These 
microbeads are coated with specific antibody which is planned to attach to selected markers on the 
surface of EVs. (Tauro, et al. 2012) Another type of microbeads are surfactant free latex beads, 
usually made of polystyrene.(Fitzner, et al. 2011)  
One method that is based on immunoaffinity uses synthetic peptide called venceremin to isolate 
extracellular vesicles from cell cultures and biologic fluids. Venceremin has a specific affinity to 
heat-shock proteins which have been associated to extracellular vesicles. This method needs a pre-
purification step to remove cell debris and it is usually performed by centrifugation or filtering with 
0,22  µm filter. (Ghosh, et al. 2014). 
 
1.4.6. Acoustic purification 
One of the newest innovations is an acoustic nanofiltration system. Acoustic purification of 
extracellular vesicles uses ultrasound waves to separate particles with different sizes from other 
components of biological sample. Size of wanted particles can be chosen electrically by adjusting 
acoustic power and flow speed of sample. Mechanical properties like size, density and 
compressibility of vesicles are the factors that affect how much force they experience. (Lee, et al. 
2015) 
Advantages of acoustic purification compared to older techniques are that it uses smaller sample 
volumes and it’s also inexpensive and faster. Either this technique doesn’t require labeling of 
samples. Also it may have a smaller sample loss than for example ultracentrifugation or 
ultrafiltration. (Lee, et al. 2015)  
 
1.4.7. Microfluidic isolation  
Compared to developing microfluidic isolation, traditional techniques like ultracentrifugation are 
less accurate resulting in weaker purity. It could be said that these older methods are only directed 
to concentration of extracellular vesicles but not for isolating them. Purity of EV samples is 
important especially when samples are intended to be used in biomarker studies. Higher purity may 
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increase the accuracy of testing of diseases. In addition that ultracentrifugation is not so accurate it 
is also time consuming. Ultracentrifugation takes time from 2- 10 hours. Using of magnetic beads 
with antibody coating purity is higher compared to ultracentrifugation. Also yield of extracellular 
vesicles is higher. One problem with magnetic beads is that they don’t work to other vesicles than 
those which contain the protein of interest which leads to lack of detection of other potentially 
present vesicles. This naturally distort the results.(Liga, et al. 2015) 
 
 
1.4.8. Hydrostatic dialysis 
Another new technique, which utilizes hydrostatic dialysis, is developed to isolate extracellular 
vesicles from urine. Urine samples are centrifuged first at 2000 x g to remove impurities as bacteria 
and cell debris. After that liquid sample is filtered with 1000 kDa dialysis membrane using 
hydrostatic pressure. Advantages of this method are that smaller space is required to storage 
samples and ultracentrifugation is not needed. (Musante, et al. 2014) 
 
1.4.9. Commercial isolation kits 
Nowadays there are also commercially available exosome isolation kits like Exoquick™ (System 
Biosciences), Exo-spin (Cell Quidance Systems), Total Exosome Isolation™ (Life Technologies) 
which are relatively easy and inexpensive to use. Common to these kits are that high-velocity 
ultracentrifugation is not needed but such as traditional ultracentrifugation, use of these kits is also 
time consuming because in majority over-night incubation is needed. Disadvantage of commercial 
kits occurs also in purity of samples which remains below the level of for example OptoPrep 
density gradient centrifugation. 
 
1.5. DETECTION METHODS OF MICROPARTICLES 
 
1.5.1. Flow cytometry 
Flow cytometry is the most common method for analysis of extracellular vesicles in blood in 
clinical use. Small size of extracellular vesicles causes problems with accuracy of flow cytometry. 
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Size of extracellular vesicles compared to human cells varies from 1/200
th 
to 1/10
th
 part. (Inglis, et 
al. 2015) Lower limit of detection range in most used flow cytometers is 500 nm. (Minciacchi, et al. 
2015)  
One problem of this method is a difficult detection of false positive events. Main reasons for this are 
that extracellular vesicles express a relatively low number of antigens, which makes the detection 
difficult and the background noise may be high because of challenges in washing steps after 
staining. Some optimization techniques for use of flow cytometry in identification of extracellular 
vesicles exists. (Inglis, et al. 2015) Study which was performed in 2012 pointed out that nano-sized 
particles can be quantified precisely. (van der Vlist, et al. 2012) Using of antibody-coated beads that 
are bigger than exosomes enables counting of small extracellular vesicles. (Lasser, et al. 2012) 
 
1.5.2. Dynamic light scattering 
Dynamic light scattering, also called photon correlation spectroscopy and quasi elastic light 
scattering is a technique which utilizes brownian motion to measure the size distribution of 
particles. Measured particles can be from under 1 nm to 10 µm in diameter. 
 
1.5.3. Nanoparticle tracking analysis (NTA) 
Nanoparticle tracking analysis is a frequently used method to study extracellular vesicles. In this 
technique scattered light from the measured particles is captured and computer software calculates 
absolute size distribution using brownian motion. Mean squared velocity of vesicles brownian 
motion is determined by tracking and it is used to estimate the diameter of the particle. Size range 
of detected particles ranges from 50 nm to 1µm in diameter. Though quantitative analysis can’t be 
done to particles larger than 400 nm. (Filipe, et al. 2010)  
 
1.5.4. (Tunable) Resistive pulse sensing 
In this technique the size distribution of particles in liquid sample is measured by detecting 
resistance changes when particles go through a small pore. Compared to dynamic light scattering 
and nanoparticle tracking analysis this technique is more accurate because it gives absolute size 
distribution. It is so called particle by particle analysis. Size of detectable particles can be from 50 
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nm to 10 µm. Upper limit is cause of pore size and lower limit is the smallest resistance limit that 
can be detected. This smallest detectable particle size is about 20% of pore size. One quite high 
problem with this technique is that particles may clog the pore especially when sample is unknown 
and if particles clot easily. So careful sample preparation like elimination of big objects by filtering 
is needed. (Anderson, et al. 2015)  
 
1.5.5. Molecular composition 
Molecular composition of extracellular vesicles is a widely used method to study the properties of 
extracellular vesicles. Methods for revealing molecular composition are for example western 
blotting, peptide mass mapping or immuno-EM.  
Different extracellular vesicles can be identified in the basis of their molecular composition. For 
example exosomes have many lipids and proteins typical specifically for exosomes. At least 
GTPases, Annexins, flotillins, several tetraspanins (CD9, CD62, CD 63, CD81 and CD82), HSC 70, 
HSC 90, ALIX, TSG 101, lipid-related proteins, phospholipases and many other markers can be 
used to detection of exosomes. (Simpson, et al. 2008, Conde-Vancells, et al. 2008, Vlassov, et al. 
2012) 
 
1.6. MICROSCOPIC METHODS TO STUDY EVS/ IMAGING OF EVS 
Because extracellular vesicles are nano-sized particles, their visualization requires the resolution of 
e.g. electron microscopy or atomic force microscopy. However the largest EVs can be also imaged 
with confocal microscopy.  
 
1.6.1. Confocal microscopy 
Confocal microscopy is a specialized technique of light microscopy and it has been used to 
visualize extracellular vesicles for years. Use of confocal microscopy requires staining of the 
sample with fluorescent markers. It should be remembered that the properties of visible light sets 
limitations to use of confocal microscopy in extracellular vesicle research. Wavelenght of visible 
light, properties of sample and restrictions of microscope optics result in the maximum resolution of 
about 200 nm in confocal microscopy. Resolution means the minimum distance by which two 
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objects can be detected from each other. (Lodish, et al. 2008) Size of exosomes varies between 40-
120 nm. It is therefore natural that the precise structural information about the extracellular vesicles 
can not be obtained with light microscopy. Using confocal microscopy is however possible to get 
images of movements of cell surface which is useful when the moment of vesicle budding is wanted 
to be studied.  
 
1.6.2. Transmission electron microscopy 
Transmission electron microscopy (TEM) allows better resolution than confocal microscopy. It is 
important because of the small size of extracellular vesicles. In transmission electron microscopy, 
electrons are accelelerated with high voltage and electron beam is then shoot through the sample. 
Advantage of transmission electron microscopy compared to light microscopy is that the 
wavelength of light is not limiting. Resolution obtained with TEM can easily be less than 1nm. 
Transmission electron microscopy is for this reason suitable method for studying structural 
properties of extracellular vesicles(van der Pol, et al. 2010)  
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2. AIMS OF THE STUDY 
Existence of extracellular vesicles has been known for decades but the interest in extracellular 
vesicles has grown exponentially during last fifteen years which can be seen as the increased 
amount of publications dealing with the topic.  Aim of this master’s thesis is to gather together up to 
date information about nomenclature, biogenesis, secretion and properties of extracellular vesicles. 
Thesis will also shed a light on how these vesicles could be utilized as biomarkers for cancer. Also 
the role glycosaminoglycan called hyaluronan in the field of extracellular vesicles is discussed in 
brief. Towards to end of the text existing isolation techniques and the available detection methods 
for extracellular vesicles will be discussed. Final goal of literature review of this thesis is to make 
an entity that combines importance of the extracellular vesicles and hyaluronan in cancer 
environment and development.  
The aim of the methodological part of this study was to develop and test microscopic methods for 
characterization of EVs from different sources by utilizing transmission electron microscopy and 
live cell confocal microscopy. Another aim is to set up and test the methods to study the effect of 
melanoma-derived EVs on the migration and invasion rate of target cells. These methods will be 
further developed and utilized in future studies of hyaluronan-induced EVs, their regulation, 
shedding and uptake mechanisms and effects on target cell functions. 
 
3. MATERIALS AND METHODS 
 
3.1. Cell culture 
In this thesis following cell lines were used: Stable inducible EGFP-HAS3-MV3 melanoma cell line 
and human fibroblasts. Culture medium used for both cell lines was Dulbecco’s Modified Eagle’s 
Media (DMEM, EuroClone, Pavia, Italy) with high glucose added with 10% Fetal bovine serum, 
1% L- glutamine and 1% penicillin. In the case of MV3-HAS-3 (D/S) also hygromycin B was 
added to the culture medium.  
Human mesenchymal stem cells described before in (Qu et al 2014) were cultured in MEM-α 
(HyClone, South Logan, UT, OSA) supplemented with 10 % FBS, (FBS, fetal bovine serum, 
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HyClone), 25 μg/ml streptomycin (EuroClone, Milano, Italia) and 25 U/ml penicillin (EuroClone), 
10 ng/ml of bFGF (fibroblast growth factor) and 25 µg/ml of vitamin C (Sigma). 
 
3.2. Isolation of EVs by ultracentrifugation 
Extracellular vesicles were isolated from MV3-HAS-3 melanoma cells. 1,5 million cells were seed 
to 8 x 10 cm dishes and when cells were attached to bottom, culture medium was replaced with 
vesicle-free medium. Just after changing of culture medium, doxycyclin (0,25 mg/ml) were added 
to the half of cell culture dishes and incubated for 48 hours.  
Media from culture dishes were collected to the 15 ml falcon tube and centrifuged 1200 x g 20 min 
in 4˚C. (Eppendorf Centrifuge 5810 Rotor F-34-6-38) Supernatant was then transferred to 
ultracentrifuge tubes and ultracentrifuged 110 000 x g 90 min. (Sorval Ultracentrifuge, DuPont) 
OTD Combi, rotor T865-1). After ultracentrifugation supernatants were removed and vesicles were 
dissolved to 100 µl DMEM high glucose (no additions)/tube. Vesicle samples were stored in 
eppendorf tubes -80 ˚C. 
 
3.3. Transmission electron microscopy (TEM) 
EV specimens used for transmission electron microscopy analysis were originally isolated from 
cultured GFP-HAS3 overexpressing MDCK cells, human mesenchymal stem cells, human ascites 
fluid and human synovial fluid. The thawed EV preparations were layered onto carbon coated and 
glow discharged copper grids. Thereafter, specimens were fixed in 2% paraformaldehyde for 10 
min. Next the samples were contrasted using 2% neutral uranyl acetate for 10-15 min in dark and 
embedded in 1,8% methyl cellulose (25 Ctp)/ 0,4% UA. Transmission electron microscopy was 
performed using JEOL JEM 2100F transmission electron microscope (Jeol Ltd, Tokyo, Japan) 
operated at 200 kV. Used magnifications varied from 4000-fold to 150 000-fold.  
 
3.4. Confocal microscopy 
Confocal microscopy was performed with a Zeiss Axio Observer inverted microscope (40 x NA 
1.3–objective) equipped with Zeiss LSM 700 confocal module (Carl Zeiss Microimaging GmbH, 
Jena, Germany). For live cell imaging, Zeiss XL-LSM S1 incubator with temperature and CO2 
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control was utilized. ZEN 2009 software (Carl Zeiss Microimaging GmbH) was used for image 
processing, and 3D rendering. 
For visualization of hyaluronan coat on live stem cells, a fluorescent group (Alexa Fluor 594) was 
directly coupled to HA binding complex (HABC) that has been isolated from bovine articular 
cartilage like described before (Rilla, et al. 2008) Before time lapse confocal imaging, live cell 
cultures grown on chambered coverglasses (Ibidi GmbH, Martinsried, Germany) were incubated for 
30 min at 37°C with fluorescent HABC (5 μg/ml) diluted in culture medium. 
For labeling of plasma membrane of live human stem cells, Deep Mask plasma membrane stain 
(1:4000, Invitrogen, Life Technologies Ltd, Paisley, UK) was used. The imaging was initiated 
immediately after addition of the stain. 
 
3.5. Migration assay 
Migration was studied by traditional scratch wound healing assay. For this assay 70 000 – 80 000 
fibroblasts were seeded in 12 wells in 24-well plates (see table below). After 48 hours incubation in 
37 ˚C wounds were scraped using a 200 µl pipette tip. After wounding the wells were washed once 
with 1 x PBS to remove cell debris. 
 
Treatments to migration assay:  
Wells 1-4: 
300 µl 
1:4 DMEM high glucose (no 
additions) to DMEM(1% FBS, 
1% P/S, 1% L-glutamine) 
 
Wells 5-8 
300 µl 
1:4 Vesicles from DOX- MVs in 
DMEM high glucose (no 
additions) to (1% FBS, 1% P/S, 
1% L-glutamine) 
 
Wells 9-12 
300 µl 
1:4 Vesicles from DOX+ MVs in 
DMEM high glucose (no 
additions) to (1% FBS, 1% P/S, 
1% L-glutamine) 
 
The wells were imaged using Nikon DS-L1-5M attached to light microscope in time points 0, 6, 16 
and 24 hours. 
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3.6. Invasion assay 
For invasion assay 55 000 cells were seeded onto 6 wells of a 8-well chamber slide (Ibidi GmbH, 
Martinsried, Germany). After 24 hours when wells were confluent the medium was removed and 
150µl of DMEM high glucose (1% FBS, 1% P/S, 1% L-glutamine) was pipetted to all six wells. For 
wells 1 and 2, 50 µl of DMEM high glucose (no additions) was added for control, for wells 3 and 4 
50 µl of vesicle suspension from MV3-HAS3 dox - cells and for wells 5 and 6 50 µl of vesicle 
suspension from MV3-HAS3 dox + cells was added. After 6 hour incubation, a layer of basement 
membrane extract gel (Cultrex, Trevigen Inc., Gaithensburg, MD) was added on the top of the 
monolayer. 
After 24 hour incubation, the cell cultures were fixed the actin cytoskeleton of the cells were stained 
with AlexaFluor 594-labeled phalloidin (Molecular Probes, Eugene, OR, USA) to visualize the 
invaded cells in the gel. Next the cell cultures were imaged with confocal microscope. Side views 
created from stacks of optical sections were used to estimate the invasion area covered by the cells. 
 
4. RESULTS 
 4.1. Transmission electron microscopy 
Relatively low amounts of extracellular vesicles were found in all TEM samples. Most of the 
vesicles were individual, but also some clustered vesicles were found. Also variable morphology of 
vesicles was seen in all samples. Some of the vesicles were electron dense, while some vesicles 
appeared very light. Many vesicles had a typical concave shaped morphology, some appeared 
rounded. The size distribution also varied. In cell culture samples the size range was from 30 nm to 
500 nm (Figure 4), and in human fluids from 50 nm to 1000 nm (Figure 5). We used glow 
discharge treated grids to strengthen the vesicle attachment to the grids, which improved the results 
(Figure 4D), but also increased the amount of impurities on the grids. 
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Figure 4. Transmission electron microscopy of EV preparations purified from different cell 
cultures. A) GFP-HAS3 overexpressing MDCK cells, B) GFP-HAS3 overexpressing MV3 cells C) 
Human mesenchymal stem cells D) Human mesenchymal stem cells with Glow Discharged grid 
 
 
 
 
 
 
 
Figure 5. Transmission electron microscopy of EV preparations purified from human 
biological fluids. A) human synovial fluid and B) human ascites fluid. 
A B 
A B 
C D 
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4.2. Live cell confocal microscopy    
Live cell imaging was utilized to visualize the shedding of EVs in cultured live human 
mesenchymal stem cells. Cell Mask plasma membrane marker visualized the plasma membrane 
clearly, and time lapse series of images (Figure 6) showed shedding of vesicles of different size 
derived from the plasma membrane of cells (arrows in Figure 6). 
To detect the hyaluronan coat and possible shedding of hyaluronan-coated vesicles from hMSCs, a 
fluorescently labeled hyaluronan binding probe that detects specifically hyaluronan in live cells was 
utilized. hMSCs were surrounded by a thick and intensive hyaluronan coat as an indication of active 
hyaluronan secretion. Additionally, plenty of hyaluronan-positive vesicles were detected around the 
cells (arrows in Figure 7). Many of the vesicles were attached to the plastic substratum, and were 
immobile (white arrows in Figure 7), while some vesicle movements were detected (yellow 
arrows in Figure 7), which suggests active secretion of EVs that carry hyaluronan coat on their 
membranes. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Time lapse images of a hMSC cell labelled with CellMask plasma membrane 
marker (green). Horizontal 3D projections created from a stack of optical sections are shown at 
each time point. 
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Figure 7. Hyaluronan coat and hyaluronan-positive EVs visualized by fluorescently labeled 
hyaluronan-binding probe (fHABC, red). Nucleus is stained with DNA-binding label DRAQ5 
(blue). Horizontal 3D projections created from a stack of optical sections are shown at each time 
point.  
 
4.3. Migration assay 
Human fibroblasts spread evenly through the wound during 24 hour observation time (Figure 8), 
resulting in the closure of the wounded area. However, there were no detectable differences 
between control group and EV treatments in migration efficiency of human fibroblasts (Figure 9). 
Mean migration speed of human fibroblasts was about 25 µm per hour.  
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Figure 8.  Phase contrast microscopic images of migration assays with human fibroblasts. 
Panels show examples of control cells in different time points after scratch wounding of the cultures 
(0, 6, 16 and 24 hours).  Magnification bar 500 µm. 
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µm 
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Figure 9. Migration assay. A) Effect of EVs derived from MV3 cells expressing GFP-HAS3 on 
the migration speed of human fibroblasts. Error bars indicate standard deviation (SD) of three 
independent experiments with three parallel samples in each experiment. B) Effect of EVs derived 
from MV3 cells expressing GFP-HAS3 on the speed (%) of wound closure of human fibroblasts. 
 
4.4. Invasion assay 
Invasion of fibroblasts in 3D gel was imaged with confocal microscope (Figure 10). Invasion 
efficiency was higher in fibroblasts treated with extracellular vesicles isolated from MV3-HAS3–
cells than the control group (Figure 11). No difference between extracellular vesicles isolated from 
doxycycline induced MV3-HAS3–cells and non-induced MV3-HAS3 (D/S) –cells were found. 
 
 
 
A 
 
 
 
 
 
 
 
 
B 
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Figure 10. Invasion assay. Fibroblast cultures grown under a Cultrex 3D gel. Panels show side 
views of 3D projections, created from stacks of confocal optical sections. A) Control cells without 
additions, B) cells after addition of EVs originating from GFP-HAS3-MV3 cells without 
doxycycline induction and C) after doxycycline induction. 
A 
B 
C 
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Figure 11. Effect of EVs on invasion of human fibroblasts. Invasion efficiency of fibroblasts in 
cultrex 3D gel was determined from three groups. Control group was given DMEM. EV DOX- 
group was given extracellular vesicles isolated from not induced MV3-HAS3 (D/S) cells and EV 
DOX + was given extracellular vesicles isolated from doxycycline induced MV3-HAS3 (D/S) cells. 
Error bars indicate range of duplicate samples. 
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4. DISCUSSION 
 
Extracellular vesicles seem to be everywhere and to be associated with almost all or all processes in 
the human body. The research field of extracellular vesicles is therefore exciting and full of 
possibilities. Research of extracellular vesicles is also full of pitfalls. It may sound exaggerative but 
almost everything could be done more precisely when studying extracellular vesicles. Isolation and 
analyzing procedures need to be standardized, terms could be more consistent, research equipment 
are still in its infancy and also researchers should be more patient when they are doing conclusions 
based on obtained results. Otherwise in the beginning of new type of research it could be useful to 
test all the possible ways to study the topic and then determine which way is the best. 
It is somehow interesting that when you think that you have learned something about for example 
exosome biogenesis that “fact” is invalidated in the next sentence. In turn, this all uncertainty 
inspires to questionate everything and keeps researchers alert when they analyze results from their 
own and other researchers’ studies. Being too sceptical may slow the research too much so it’s quite 
important to found a suitable compromise. 
The explosive growth of the discipline has brougth a multiple new techniques with it. The most of 
these new equipment like particle size analyzators and isolation kits for EVs need still more 
development before they are working absolutely reliably. In some cases the problem is in the 
inexperienced user and, in turn, in the equipment. For example it is quite hard to separate 
extracellular vesicles from other same sized particles in the sample with particle size analyzators. 
Somehow it may be difficult to understand that different types of EVs – exosomes and 
microvesicles – may look similar at first glance but they represent totally different entireties. 
Different type of biogenesis and cargo advocates the view that these vesicles should be separated 
when research is performed. Partly overlapping size distribution and otherwise similar 
characteristics of exosomes and microvesicles make this task hard to fulfill. Although idea of 
separating these two types of EVs to entirely separated entities may sound rational, it should be 
remembered that these two types of vesicles are actually at the same time and place. Maybe they 
will work together in order to achieve the desired result? 
International society of extracellular vesicles (ISEV) has done much to promote these topics. One 
example is the setting of basic quidelines for isolation and analysis of extracellular vesicles(Lötvall, 
et al. 2014).  
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In the future the extracellular vesicles will pretty sure be powerful tools to research, analytics and 
treatment of multiple diseases. When the EVs has been harnessed to the use of disease screening it 
will be possible to recognize pathological conditions much earlier than nowadays. For example in 
cancer analytics it may be critical if we think survival rate. It’s a fascinating thought that 
development of liquid biopsy may allow easy way to screen development of diseases which cannot 
be detected with traditional techniques at early stage. The threshold for taking liquid biopsy is also 
lower because it does not require such invasive operation as traditional biopsy. For example in some 
cases urine sample is enough and it’s also easier to give blood sample than biopsy which needs 
surgical procedure. 
 
In the practical part of this master’s thesis the aim was to study properties of extracellular vesicles 
using microscopic methods and invasion and migration assays. 
Although it may seem pointless to focus to the culturing of cells, culturing conditions of cells are 
certainly a key factor in the case of secretion of extracellular vesicles. It is easy to think that 
culturing conditions are equal if the protocol is followed but there is a number of “microchanges” 
which should be taken into account like the temperature and age of used media and additions.  Also 
pH of cell culture may be good to be monitored. 
Vesicle isolation using ultracentrifugation is quite challenging technique from the perspective that 
the pellet of vesicles is not visible.  For more accurate studies the presence of wanted extracellular 
vesicles should be determined from every isolation batch. This determination could be done for 
example with transmission electron microscopy. Also the counting of the numbers of existing 
extracellular vesicles is important for further analyses. Without these measurements the result of 
these studies are rather preliminary results than accurate results. Different variations of 
centrifugation /ultracentrifugation speeds should be tested systematically to be sure which results in 
best outcome. Especially if for example the effects of only microvesicles or exosomes are wanted to 
be tested. Also this will help to reach the best yield of extracellular vesicles overall.  
Live cell imaging with the confocal microscopy was performed to visualize the moment of budding 
of extracellular vesicle. Imaging of extracellular vesicles with confocal microscopy was done by 
staining of cell membrane with plasma membrane marker and hyaluronan binding probe. Small size 
of extracellular vesicles sets limits to the required resolution. In addition to the small size also 
relatively fast movement of EVs makes imaging difficult. Best resolution of z-stack image would be 
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achieved with high number of pictures per stack and low imaging speed. However this is not 
possible to do because of movement of EVs. In the future developing imaging equipment will result 
in higher resolution and imaging speed will be higher. Slow imaging speed is mainly due to 
mechanical properties of confocal microscope. 
Ultrastructural studies of extracellular vesicles were done succesfully. The bilipid layer and typical 
cup-shaped form of extracellular vesicles were visible in many cases. Also the size range of vesicles 
in images were as assumed. Although there were in some cases thick layer of surfactant especially 
at the border area of grids, imaging could be done without bigger problems. Also ripping of surface 
of grids made imaging more difficult in several cases. Using of Glow-Discharge treatment of grids 
increased the amount of captured vesicles but there were also high amount of other “trash”. 
Anyway, in the future experiments, more concentrated EV preparations are required to catch a 
sufficient number of vesicles for reliable analysis.  
In the invasion assay the major shortcoming may be the number of repeats which was only one. 
This was because of a tight deadline of assay. In the future, more repetition would be done for better 
reliability. Another shortcoming may be possible practical problems as light drying of cells in used 
Ibidi chamber slides were observed. This may has changed result especially in the case that the 
drying were not uniform in all wells. In the future comparing of different cell lines and culturing 
conditions may lead to better accuracy of results.  
In the migration assay there were no significant changes between the control group and treatments. 
The growth rate of used fibroblast was so high in every group that possible differences between 
groups may not be detected because of that. On source of error is actually the use of fibroblast 
because they spread rapidly through the wound. They do not grow as a steadily moving wall.  Thus 
the use of epithelial cells may give more accurate results in future experiments. 
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